Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Background. Multiple sclerosis (MS) is an autoimmune inflammatory disease of central nervous system (CNS). MS affects quality of Life (QOL) due to physical disability and other associated problems. Disease-modifying agents like interferon beta (IFNB) have been widely utilized in this patient populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolfazli, R., Hosseini, A., Gholami, Kh., Javadi, M. R., Torkamandi, H., Emami, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423918/
https://www.ncbi.nlm.nih.gov/pubmed/22928117
http://dx.doi.org/10.5402/2012/786526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423918/
https://www.ncbi.nlm.nih.gov/pubmed/22928117
http://dx.doi.org/10.5402/2012/786526

Ejemplares similares